tiprankstipranks

BioMarin price target raised to $80 from $78 at Scotiabank

Scotiabank raised the firm’s price target on BioMarin (BMRN) to $80 from $78 and keeps a Sector Perform rating on the shares. The firm is raising its price target on the stock following a Q4 Voxzogo beat and bullish 2025 revenue outlook, the analyst tells investors. Scotiabank, however, maintains its rating due to concerns about the potential competitive threats to the Voxzogo franchise.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue